AHNS 2021 - AHNS 10th International Conference on Head and Neck Cancer: “Survivorship through Quality and Innovation” (Virtual Meeting)
Jul 22 - Jul 25, 2021 | ChicagoILUS
LARVOL is not affiliated with AHNS 10th International Conference on Head and Neck Cancer: “Survivorship through Quality and Innovation” (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 14 abstracts linked to Trials
[VIRTUAL] THE REVERSAL OF IMMUNE EXCLUSION MEDIATED BY TADALAFIL AND AN ANTI-TUMOR VACCINE ALSO INDUCES PDL1 UP REGULATION IN RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA: FINAL ANALYSIS INCLUDING CLINICAL OUTCOMES OF A PHASE I CLINICAL TRIAL
[VIRTUAL] A phase 2 clinical trial of ALKS 4230 combined with pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): the ION-01 trial
[VIRTUAL] A phase I study evaluating NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with advanced cancers
[VIRTUAL] FDG-PET identifies pathological responses early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma
[VIRTUAL] Elevation of T-Cell-Derived Cytokines Could Predispose Patients Treated with Immune Checkpoint Inhibitors to Developing Immune-Related Adverse Events
[VIRTUAL] LIBRETTO-531: A Phase III study of selpercatinib vs investigator choice of cabozantinib or vandetanib in patients with multikinase inhibitor-naïve advanced or metastatic RET-mutant medullary thyroid cancer (MTC)
[VIRTUAL] Phase II randomized trial of neo-adjuvant chemotherapy followed by surgery and post-operative radiation versus surgery and post-operative radiation for organ preservation of T3 and T4a nasal and paranasal sinus squamous cell carcinoma (NPNSCC): A trial of
[VIRTUAL] PATHOS: A Phase III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV)-positive oropharyngeal cancer
[VIRTUAL] A phase I study of radiation enhancing functionalized hafnium oxide nanoparticles in cisplatin-ineligible patients with locally advanced HNSCC
[VIRTUAL] Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: Preliminary Results of the Pilot MANTLE trial
[VIRTUAL] Efficacy and safety of larotrectinib in patients with advanced TRK fusion salivary gland cancer
[VIRTUAL] Hypoglossal palsy in the pathogenesis of late-radiation associated dysphagia
[VIRTUAL] USE OF THE CLAVIEN-DINDO CLASSIFICATION OF SURGICAL COMPLICATIONS IN NEOADJUVANT IMMUNOTHERAPY CLINICAL TRIALS FOR HEAD AND NECK CANCER
[VIRTUAL] Assessing Risk of Oral Cancer Progression Using an S100A7 Immunohistochemical Signature-based Assay